Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
02/2003
02/11/2003CA2141554C Morphogen-induced nerve regeneration and repair
02/11/2003CA2109516C Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
02/11/2003CA2102606C Compositions for the treatment of chronic fatigue syndrome
02/11/2003CA2078689C Chimeric antibodies with receptor binding ligands in place of their constant region
02/11/2003CA2068871C Non-glycosylated fgf-4 and compositions containing the same
02/11/2003CA2005704C Pneumolysin mutants and pneumococcal vaccines made therefrom
02/08/2003CA2396616A1 Modified cdna for high expression levels of factor viii and its derivatives
02/06/2003WO2003010317A1 Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine
02/06/2003WO2003010315A1 Abca7 splicing variant
02/06/2003WO2003010314A2 Gmg-2 polynucleotides and polypeptides and uses thereof
02/06/2003WO2003010313A1 Novel diphtheria anatoxins and their use as carrier
02/06/2003WO2003010310A1 Method of examining allergic disease
02/06/2003WO2003010306A1 Viral mutants that selectively replicate in targeted human cancer cells
02/06/2003WO2003010301A1 New isolated dendritic cells, a process for preparing the same and their use in pharmaceutical compositions
02/06/2003WO2003010291A2 Treatment of immune disorders and b cell disorders
02/06/2003WO2003010284A2 Antisense modulation of c-reactive protein expression
02/06/2003WO2003010283A2 Antisense modulation of pka regulatory subunit rii beta expression
02/06/2003WO2003010281A2 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics
02/06/2003WO2003010205A1 Genes induced by hypoxia
02/06/2003WO2003010202A1 Concatameric immunoadhesion
02/06/2003WO2003010201A2 Blood group antigen fusion polypeptides and methods of use thereof
02/06/2003WO2003010200A2 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
02/06/2003WO2003010197A2 Gmg-1 polynucleotides and polypeptides and uses thereof
02/06/2003WO2003010196A2 Variants and exons of the glyt1 transporter
02/06/2003WO2003010192A2 An inducer of apoptosis
02/06/2003WO2003010191A1 New cationic peptides of the dermaseptin family isolated from the skin secretion of phyllomedusa hypochondrialis
02/06/2003WO2003010188A1 Production of high molecular mass lectins
02/06/2003WO2003010141A2 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure
02/06/2003WO2003010140A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure
02/06/2003WO2003010139A2 Antisense modulation of hormone-sensitive lipase expression
02/06/2003WO2003009898A1 Treatment of hair follicle with neurokinin 1 receptor antagonists
02/06/2003WO2003009881A2 Novel targeted delivery system for bioactive agents
02/06/2003WO2003009871A2 Inhibitors of plasminogen activator inhibitor for decreasing body mass
02/06/2003WO2003009867A1 Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases
02/06/2003WO2003009866A1 Use of the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent
02/06/2003WO2003009865A1 Agonists and antagonists of energen for use in the treatment of metabolic disorders
02/06/2003WO2003009864A1 Agonists and antagonists of disomet for the treatment of metabolic disorders
02/06/2003WO2003009863A1 Agonists and antagonists of cofoxin for use in the treatment of metabolic disorders
02/06/2003WO2003009862A1 Agonists and antagonists of modumet for use in the treatment of metabolic disorders
02/06/2003WO2003009861A1 Agonists and antagonists of metabolix in the treatment of metabolic disorders
02/06/2003WO2003009847A1 Substituted piperidines as modulators of the melanocortin receptor
02/06/2003WO2003009841A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
02/06/2003WO2003009813A2 Methods of treating neuropilin-mediated diseases
02/06/2003WO2003009808A2 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
02/06/2003WO2003009804A2 Conformationally constrained parathyroid hormone (pth) analogs
02/06/2003WO2003009799A1 Liquid composition comprising an enzymatic anti-inflammatory agent and a mucolytic
02/06/2003WO2003009779A2 Delivery of therapeutic capable agents
02/06/2003WO2003009778A2 Methods and devices for delivery of therapeutic capable agents with variable release profile
02/06/2003WO2003009777A2 Delivery of therapeutic capable agents
02/06/2003WO2003009740A2 Methods for treating or preventing sclerotic disorders using cd2-binding agents
02/06/2003WO2003009704A2 Enteral compositions for the prevention and/or treatment of sepsis
02/06/2003WO2002095034A3 A retinoic acid metabolizing cytochrome p450
02/06/2003WO2002093177A3 Assays for identifying modulators of rhomboid polypeptides
02/06/2003WO2002092772A3 Antisense modulation of ptp1b expression
02/06/2003WO2002089828A3 Interferons in the treatment of ischemia
02/06/2003WO2002089773A3 Pharmaceutical compositions comprising cyclosporin
02/06/2003WO2002083722A3 Methods and means for use of hla-dq restricted t-cell receptors and hla-dq-binding prolamine-derived peptides
02/06/2003WO2002079146A3 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
02/06/2003WO2002072805A3 Thymidylate synthase
02/06/2003WO2002070001A3 Use of lp82 to treat hematopoietic disorders
02/06/2003WO2002069689A3 Gssp4 polynucleotides and polypeptides and uses thereof
02/06/2003WO2002068467A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
02/06/2003WO2002067910A3 The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment
02/06/2003WO2002063005A3 Lipid-associated molecules
02/06/2003WO2002063002A3 Novel human transporter protein and polynucleotides encoding the same
02/06/2003WO2002060950A3 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
02/06/2003WO2002058535A3 Use of combretastatin a4 and its prodrugs as an immune enhancing therapy
02/06/2003WO2002057308A3 Zinc finger polypeptides and their use
02/06/2003WO2002055543A3 Hybrid peptides for treatment of bacteremia and septicemia
02/06/2003WO2002050263A3 Methods_for treating tissue damage by bone-marrow derived stem cells
02/06/2003WO2002046380A3 Protein kinase
02/06/2003WO2002044394A3 Targetet retoviral vectors for cancer immunotherapy
02/06/2003WO2002039995A9 Combination therapy for estrogen-dependent disorders
02/06/2003WO2002036781A3 Regulation of human glutathione-s-transferase
02/06/2003WO2002034887A3 Maturation of dendritic cells
02/06/2003WO2002030470A9 Methods and compositions for nucleic acid delivery
02/06/2003WO2002030355A3 Composition and method of alleviating adverse side effects and/or enhancing efficacy of agents that inhibit aromatase
02/06/2003WO2002028900A9 Tach: new tnf-receptor family nucleic acids and polypeptides
02/06/2003WO2002020722A3 Methods and compositions for in vitro targeting
02/06/2003WO2002019963A3 Synthetic erythropoiesis stimulating proteins
02/06/2003WO2002018577A3 48921, a novel human gtp releasing factor and uses therefor
02/06/2003WO2002016602A3 Compositions and methods for the diagnosis and treatment of tumor
02/06/2003WO2002016592A3 Atcr-1, a human acyltransferase and uses thereof
02/06/2003WO2002016582A3 Human sodium-sugar symporter family member and uses thereof
02/06/2003WO2002016413A8 Cripto tumour polypeptide
02/06/2003WO2002014470A3 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth
02/06/2003WO2002010217A9 Endothelial cell expression patterns
02/06/2003WO2002000717A9 Novel co-stimulatory molecules
02/06/2003WO2001096548A3 Human n-acetyltransferase family member and uses thereof
02/06/2003WO2001094409A3 Compositions and methods for the therapy and diagnosis of pancreatic cancer
02/06/2003WO2001093897A9 Angiostatin and endostatin binding proteins and methods of use
02/06/2003WO2001091801A3 Methods of transducing neural cells using lentivirus vectors
02/06/2003WO2001088199A3 Identification and modulationof of a t helper-1 and t helper-2 cells
02/06/2003WO2001085930A9 Methods and compounds for modulating melanocortin receptor ligand binding and activity
02/06/2003WO2001083769A9 Crystallization of 4-diphosphocytidyl-2-c-methylerythritol synthesis
02/06/2003WO2001079285A9 Methods and compositions for the treatment of fibrotic conditions and impaired lung function and to enhance lymphocyte production
02/06/2003WO2001077330A3 G protein-coupled receptors
02/06/2003WO2001075179A3 Preprocalcitonin as tumor rejection antigen precursor and uses thereof
02/06/2003WO2001070765A9 Receptor-binding compounds and methods for identifying them
02/06/2003WO2001064874A9 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis
1 ... 1908 1909 1910 1911 1912 1913 1914 1915 1916 1917 1918 1919 1920 1921 1922 1923 1924 1925 1926 1927 1928 ... 3163